Left Ventricular Mural Thrombus-Atypical Myocardial Infarction Presenting With Upper Abdominal Pain and Vomiting: Imaging Diagnosis, Treatment, and Prognosis
Executive Clinical Summary
“Upper abdominal pain and vomiting.”
When a patient presents to the emergency department with these symptoms, gastrointestinal disease is often considered first. However, particularly in older adults and patients with diabetes or cardiovascular risk factors, these symptoms may represent an atypical presentation of acute myocardial infarction.
The key lesson from this case is not simply recognizing the symptoms. It is recognizing the clinical connection between myocardial infarction and the subsequent development of left ventricular mural thrombus (LVT).
A woman in her 70s with diabetes presented to the emergency department with a 3-day history of upper abdominal pain and vomiting. Electrocardiography demonstrated normal sinus rhythm with pathological Q waves and T-wave inversions in the precordial leads, while high-sensitivity troponin was elevated to 686 ng/L. Coronary angiography subsequently demonstrated complete occlusion of the mid left anterior descending artery (LAD). Left ventriculography showed regional wall-motion abnormality in the LAD territory and an apical filling defect. Transthoracic echocardiography (TTE) demonstrated a reduced left ventricular ejection fraction (LVEF) of 37% and a thrombus at the left ventricular apex.
The pathophysiological sequence can therefore be summarized as:
LAD occlusion → anterior/apical myocardial infarction → apical akinesia and left ventricular dysfunction → blood stasis → left ventricular mural thrombus
Left ventricular mural thrombus is not simply an incidental cardiac finding. If the thrombus embolizes, it can travel to the cerebral or systemic arterial circulation and cause ischemic stroke or systemic arterial embolism.
Key Clinical Questions
When a left ventricular mural thrombus is identified on imaging, the important question is not simply:
“Is there a thrombus?”
The following questions are equally important:
Where is the thrombus located?
Does its location correspond to the infarcted myocardial territory?
What is the degree of apical wall-motion abnormality?
Is the thrombus laminated or protruding into the ventricular cavity?
Is it attached to the ventricular wall?
Is it mobile?
How severely is left ventricular function impaired?
Is there an apical aneurysm or persistent dyskinesia?
How high is the risk of systemic embolization?
Is anticoagulation indicated?
When should follow-up imaging be performed?
These questions are central to the imaging evaluation and clinical management of LVT.
Introduction
Left ventricular mural thrombus is an important complication that can occur after myocardial infarction. It is particularly associated with extensive anterior myocardial infarction, LAD territory involvement, apical akinesia or dyskinesia, and reduced left ventricular systolic function.
The incidence of LVT after myocardial infarction has decreased with advances in reperfusion therapy. Nevertheless, it remains clinically important in patients with extensive myocardial injury and severe regional wall-motion abnormalities.
One of the challenges in diagnosing LVT is that it does not always appear as an obvious intracavitary mass. The left ventricular apex can be technically difficult to evaluate, and small thrombi or thrombi closely adherent to the ventricular wall may be difficult to detect.
Therefore:
A negative echocardiographic examination is not necessarily equivalent to definitive exclusion of left ventricular thrombus.
This distinction is clinically important.
Clinical Hook: When Upper Abdominal Pain Should Raise Suspicion for Myocardial Infarction
In this case, the patient's principal symptoms were upper abdominal pain and vomiting rather than typical chest pain.
These symptoms may occur with many gastrointestinal disorders, including gastritis, biliary disease, and gastrointestinal infection. However, myocardial ischemia may present without classic chest pain, particularly in older adults and patients with diabetes.
Therefore, in a high-risk patient with persistent upper abdominal pain and vomiting, myocardial infarction should not be excluded solely because the pain is abdominal rather than thoracic.
In this case, the combination of ECG abnormalities and elevated troponin prompted cardiac evaluation. Subsequent coronary angiography demonstrated complete LAD occlusion.
At that point, the imaging question should not stop at confirming myocardial infarction.
The next questions are:
How severely is the apex affected?
Is there significant regional wall-motion abnormality?
Has a left ventricular thrombus developed?
Learning Objectives
After reading this article, readers should be able to:
Explain the major mechanisms underlying left ventricular mural thrombus formation.
Understand the anatomical and functional relationship between myocardial infarction and LVT.
Distinguish the roles and limitations of echocardiography, CT, and cardiac MRI.
Understand why thrombus morphology and mobility are clinically important.
Recognize the major differential diagnoses of an intracavitary left ventricular filling defect.
Understand the principles of anticoagulation and follow-up imaging.
Anatomy Review: Why Is the Left Ventricular Apex Important?
The left ventricle is the principal cardiac chamber responsible for delivering oxygenated blood to the systemic circulation.
During normal ventricular contraction, coordinated contraction of the ventricular wall—including the apex—promotes efficient ejection of blood toward the aorta.
When an LAD territory myocardial infarction occurs, the anterior wall and apex may develop marked hypokinesia, akinesia, or dyskinesia.
When the apex becomes akinetic or dyskinetic, normal intracavitary blood flow is altered. Blood may become relatively stagnant within the affected region, creating an environment favorable for thrombus formation.
Therefore, evaluation of myocardial infarction should not rely exclusively on the numerical LVEF. The regional distribution and severity of wall-motion abnormalities are also critical.
Case Presentation
Patient Profile
A woman in her 70s with diabetes presented to the emergency department with a 3-day history of upper abdominal pain and vomiting.
ECG and Laboratory Findings
Electrocardiography demonstrated normal sinus rhythm with pathological Q waves and T-wave inversions in the precordial leads.
High-sensitivity troponin was elevated to 686 ng/L.
Coronary Angiography
Coronary angiography demonstrated complete occlusion of the mid left anterior descending artery (LAD).
Left Ventriculography
Left ventriculography demonstrated regional wall-motion abnormality involving the LAD territory and a filling defect at the left ventricular apex.
Transthoracic Echocardiography
TTE demonstrated a reduced LVEF of 37% and a thrombotic structure at the left ventricular apex that was distinguishable from the ventricular wall.
Final Diagnosis
Myocardial infarction complicated by left ventricular mural thrombus
Pathophysiology: Why Does Left Ventricular Thrombus Develop After Myocardial Infarction?
The development of LVT can be understood using Virchow's triad, which consists of:
Blood stasis
Endothelial or endocardial injury
Hypercoagulability
All three mechanisms may coexist following acute myocardial infarction.
1. Blood Stasis
Extensive LAD territory myocardial infarction can significantly reduce contraction of the anterior wall and apex.
Under normal circumstances, coordinated ventricular contraction promotes efficient emptying of the apex. When the apex becomes akinetic or dyskinetic, blood flow becomes sluggish and local stasis develops.
2. Myocardial Injury and Endocardial Abnormality
Myocardial infarction produces myocardial necrosis, inflammation, and tissue injury.
Changes involving the endocardial surface may further promote thrombus formation within the ventricular cavity.
3. Hypercoagulability
Acute myocardial infarction is associated with systemic inflammatory and coagulation activation.
Thus, LVT should not be regarded as the result of a single mechanism. Rather, it develops through the combined effects of:
myocardial injury + regional wall-motion abnormality + blood stasis + activation of coagulation
Epidemiology
The reported incidence of left ventricular thrombus varies according to the patient population, type of myocardial infarction, reperfusion strategy, and imaging technique.
In the literature cited in the case material, LVT has been reported in approximately 15% of STEMI patients when optimal imaging is used, with rates reaching approximately 25% in patients with anterior myocardial infarction.
Important risk factors include:
| Risk Factor | Clinical Significance |
|---|---|
| Anterior myocardial infarction | Major high-risk setting |
| LAD occlusion | Increased risk of apical and anterior wall injury |
| Apical akinesia | Promotes local blood stasis |
| Extensive myocardial infarction | Greater likelihood of LV dysfunction |
| Reduced LVEF | Increased potential for blood stasis |
| Left ventricular aneurysm | Persistent abnormal intracavitary flow |
| Severe regional wall-motion abnormality | Promotes thrombus formation |
| Delayed reperfusion | May result in more extensive myocardial injury |
An important practical point is that LVEF alone should not be used to determine thrombus risk. The location and severity of regional wall-motion abnormalities are equally important.
Clinical Presentation
Left ventricular mural thrombus itself often causes no specific symptoms and is frequently detected during evaluation of myocardial infarction or heart failure.
The major concern is systemic embolization.
Cerebral Embolism
One of the most serious complications is embolization to the cerebral circulation.
Patients may develop:
Sudden unilateral weakness
Facial paralysis
Aphasia
Visual field disturbance
Other focal neurological deficits
Systemic Arterial Embolism
An embolized thrombus may also travel to the renal, splenic, mesenteric, or peripheral arterial circulation.
Therefore, when an acute arterial occlusion occurs without an obvious local cause, a cardiac embolic source should be considered.
Heart Failure
Heart failure symptoms are generally more directly related to myocardial infarction and left ventricular dysfunction than to the thrombus itself.
Dyspnea, fatigue, and peripheral edema may occur when significant ventricular dysfunction is present.
Imaging Features: What Radiologists Should Look for in Left Ventricular Mural Thrombus
1. Transthoracic Echocardiography
TTE is an important initial imaging modality for evaluating LVT.
Its major advantages include rapid availability, relatively low cost, and the ability to perform the examination at the bedside.
TTE can simultaneously evaluate:
LVEF
Regional wall-motion abnormalities
Left ventricular apex
Thrombus location
Thrombus size
Thrombus morphology
Thrombus mobility
Protrusion into the ventricular cavity
However, an important diagnostic pitfall should be emphasized.
A negative TTE does not necessarily exclude left ventricular thrombus.
If apical visualization is inadequate, or if the thrombus is small and closely adherent to the ventricular wall, detection may be difficult.
Figure 1. Left Ventriculography
Figure 1. Apical filling defect on left ventriculography
Radiologic Interpretation
Left ventriculography demonstrates regional wall-motion abnormality corresponding to the LAD territory, together with a filling defect at the left ventricular apex.
The filling defect represents a space-occupying abnormality within the apical ventricular cavity that differs from the expected contrast opacification of the normal left ventricular lumen and strongly suggests left ventricular mural thrombus.
Key Diagnostic Points
Apical filling defect
Regional wall-motion abnormality in the LAD territory
Anatomical correlation with myocardial infarction and left ventricular dysfunction
Location compatible with thrombus formation in the setting of apical akinesia
Clinical Significance
An apical filling defect should not be interpreted as an isolated imaging finding.
The coronary anatomy, regional wall motion, and intracavitary filling pattern should be integrated.
When LAD occlusion and apical akinesia are accompanied by an apical filling defect, the pretest probability of LVT is substantially increased.
Figure 2. Transthoracic Echocardiography
Figure 2. Left ventricular apical thrombus on transthoracic echocardiography
Radiologic Interpretation
TTE demonstrates a reduced LVEF of 37%, with a thrombotic structure at the left ventricular apex that can be distinguished from the ventricular wall.
Key Diagnostic Points
LVEF 37%
Thrombotic lesion adjacent to the apex
Associated regional wall-motion abnormality due to myocardial infarction
Evaluation of attachment, protrusion, and mobility is important
Clinical Significance
In this case, echocardiography provided information not only about the presence of thrombus but also about left ventricular dysfunction and apical wall-motion abnormality.
Once a thrombus is identified, its morphology, protrusion, and mobility should be documented because these characteristics may influence embolic risk assessment.
CT: Findings That Should Not Be Missed
Although left ventriculography and echocardiography were central to the diagnosis in this case, left ventricular thrombus can also be detected incidentally on CT performed for other indications.
This is particularly relevant when patients with upper abdominal pain or vomiting undergo chest, abdominal, or chest-abdominal CT.
On CT, radiologists should pay attention to:
Low attenuation or filling defect at the left ventricular apex
Myocardial changes corresponding to a coronary territory
Left ventricular apical aneurysm
Morphological evidence of regional ventricular dysfunction
Intracavitary mass-like abnormalities
However, routine non-cardiac CT has limitations for evaluating small LVT.
The appearance of the ventricular cavity depends on factors such as contrast timing, cardiac output, heart rate, and image acquisition parameters.
Therefore, when an apical filling defect is suspected on CT, echocardiography or cardiac MRI may be useful for further evaluation, depending on the clinical situation.
Cardiac MRI: When the Diagnosis Remains Uncertain
Cardiac magnetic resonance imaging (CMR) can play an important role in characterizing left ventricular thrombus.
Delayed enhancement or late gadolinium enhancement techniques can exploit differences in tissue characteristics between thrombus, myocardium, and other intracardiac masses.
The literature cited in the case material reports high diagnostic performance for contrast-enhanced MRI, with reported sensitivity and specificity of approximately 88% and 99%, respectively.
Systematic reviews have also suggested that late gadolinium enhancement CMR and contrast-enhanced TTE may provide better thrombus detection than non-contrast TTE.
A practical imaging pathway can therefore be summarized as:
Myocardial infarction + apical wall-motion abnormality
↓
TTE
↓
Thrombus suspected or image quality inadequate
↓
Contrast-enhanced TTE or CMR
This does not mean that CMR should always be performed first.
In the emergency setting, TTE is often the initial examination because it is rapid, accessible, and capable of providing immediate functional information.
In other words:
The most accurate test and the first test are not necessarily the same test.
Differential Diagnosis: Is Every Left Ventricular Filling Defect a Thrombus?
No.
When an intracavitary mass or filling defect is identified in the left ventricle, several possibilities should be considered.
| Differential Diagnosis | Typical Imaging Features | Helpful Clinical/Anatomical Clues |
|---|---|---|
| Mural thrombus | Often located at the apex or infarcted myocardium | Associated with myocardial infarction and wall-motion abnormality |
| Vegetation | Usually attached to a valve | Related to valvular structures |
| Papillary muscle abnormality | Adjacent to the mitral valve apparatus | Characteristic anatomical location |
| Rhabdomyoma | Mass-like lesion | More commonly considered in pediatric patients |
| Sarcoma | Irregular or infiltrative mass | Tumor-like characteristics |
| Normal trabeculation | Normal ventricular anatomy | Follows expected anatomical structures |
| Apical pseudo-lesion | Apparent filling defect due to heterogeneous contrast mixing | May disappear or change on different imaging phases |
In this case, the combination of myocardial infarction, LAD territory wall-motion abnormality, apical filling defect, and echocardiographic confirmation of thrombus strongly supports the diagnosis of left ventricular mural thrombus.
Why Does Thrombus Morphology Matter?
Once LVT is identified, simply documenting “thrombus present” may not provide enough information for clinical decision-making.
The imaging report should ideally describe:
Location
Is the thrombus located at the apex, anterior wall, septum, or another region?
Size
The dimensions of the thrombus should be documented whenever feasible.
Morphology
Is it broadly attached to the ventricular wall, laminated, or protruding into the ventricular cavity?
Mobility
Does the thrombus move independently or significantly with cardiac contraction?
Protrusion
Does the thrombus project into the ventricular cavity?
Tissue Characteristics
When CMR is performed, tissue characterization may help distinguish thrombus from myocardium or other intracardiac masses.
Particular attention should be paid to large, protruding, and mobile thrombi, as these morphological characteristics are clinically relevant when assessing embolic risk.
Multimodality Imaging Comparison
| Modality | Advantages | Limitations | Primary Role |
|---|---|---|---|
| TTE | Rapid and widely available | Limited apical visualization in some patients | Initial evaluation |
| Contrast TTE | Improved endocardial/apical visualization | Requires contrast administration | Further evaluation when standard TTE is equivocal |
| Cardiac MRI | Excellent tissue characterization | Time, cost, and availability | Problem-solving examination |
| CT | May reveal thrombus incidentally | Non-cardiac protocols may be suboptimal | Complementary evaluation |
| LV angiography | Demonstrates wall motion and filling defects | Invasive | Assessment during coronary angiography |
The important principle is not to identify one modality as universally superior.
Instead, each modality should be used according to its clinical role, diagnostic question, availability, and patient condition.
Practical Imaging Algorithm
Treatment: What Should Be Done When LVT Is Identified?
The central treatment strategy for confirmed left ventricular thrombus is systemic anticoagulation.
The major objectives are:
Prevent further thrombus enlargement.
Reduce the risk of systemic embolization.
Historically, vitamin K antagonists such as warfarin have been widely used. Direct oral anticoagulants (DOACs) are increasingly being used in clinical practice.
However, it is inappropriate to conclude that DOACs are universally superior or that warfarin is always preferred.
Recent studies suggest that DOACs may have similar or potentially favorable outcomes compared with warfarin with respect to thrombus resolution, stroke/systemic embolism, and bleeding. However, much of the evidence remains based on observational studies and relatively small randomized trials.
Therefore, anticoagulant selection should consider:
Bleeding risk
Concomitant antiplatelet therapy
Renal function
Drug interactions
Thromboembolic risk
LV function
Thrombus morphology and mobility
Other cardiovascular comorbidities
How Long Should Anticoagulation Continue?
The duration of anticoagulation should not be determined solely by a fixed calendar interval.
Follow-up imaging and the patient's ongoing thrombotic and bleeding risks should be considered.
The case material describes approximately 3 months of anticoagulation followed by repeat imaging as a commonly used practical strategy for confirmed LVT. Continued anticoagulation may be considered when thrombus persists or significant risk factors remain.
Important factors include:
Persistent thrombus
Large thrombus
High mobility
Persistent severe LV dysfunction
LV aneurysm
Persistent apical dyskinesia
Previous embolic events
The decision should ultimately be individualized according to the clinical context and current guideline recommendations.
Why Was Revascularization Not Performed in This Case?
In this case, a significant amount of time had elapsed since symptom onset, the patient's symptoms had improved, and subsequent evaluation demonstrated established myocardial necrosis. Revascularization was therefore not performed, and guideline-directed medical therapy together with therapeutic anticoagulation was initiated.
An important clinical distinction should be emphasized:
Coronary revascularization and anticoagulation for LV thrombus are separate therapeutic decisions.
The question of whether a coronary artery can or should be revascularized after a prolonged period of myocardial injury is different from the question of whether an established LV thrombus requires anticoagulation to reduce systemic embolic risk.
Thus, three parallel clinical issues must be considered:
Coronary occlusion → assessment of revascularization
Left ventricular thrombus → embolic risk and anticoagulation
LV dysfunction → heart failure management and long-term prognosis
Prognosis: What Determines the Outcome of LVT?
The presence of LVT does not automatically mean that the long-term prognosis will be poor.
If the thrombus resolves and LV function improves, the long-term risk may decrease.
Conversely, persistent thrombus combined with persistent LV dysfunction may indicate continued thromboembolic risk.
Therefore, the key question during follow-up is not simply:
“Has the thrombus disappeared?”
It is also:
“Has left ventricular function recovered?”
Follow-up imaging should assess:
| Follow-up Parameter | What to Evaluate |
|---|---|
| LVEF | Recovery of LV systolic function |
| Apical wall motion | Persistent akinesia/dyskinesia |
| Thrombus size | Reduction, enlargement, or stability |
| Thrombus morphology | Change in attachment or protrusion |
| Mobility | Change in thrombus mobility |
| LV aneurysm | Presence or persistence |
| New thrombus | Development of additional thrombus |
Persistent severe LV dysfunction, apical dyskinesia, or LV aneurysm should prompt careful reassessment of ongoing thrombotic risk.
Radiologist Interpretation: A Practical Approach
When LVT is suspected, a systematic approach is useful.
STEP 1. Identify the myocardial infarction territory
If an LAD territory infarction is present, actively evaluate the apex for thrombus.
STEP 2. Evaluate regional wall motion
Do not rely exclusively on the LVEF value. Assess the apex and anterior wall for hypokinesia, akinesia, or dyskinesia.
STEP 3. Carefully inspect the apex
The apex is a common location for LVT but can be technically challenging to evaluate.
Determine whether the apex has been adequately visualized.
STEP 4. Characterize the thrombus
Document whether it is:
Mural
Laminated
Protruding
Mobile
Broad-based
Closely adherent to the wall
STEP 5. Consider additional imaging when necessary
If TTE is technically limited or clinical suspicion remains high despite an equivocal examination, contrast-enhanced TTE or CMR may be appropriate.
Why Should We Reconsider “Upper Abdominal Pain + Vomiting”?
Upper abdominal pain and vomiting should not automatically be attributed to gastrointestinal disease in older adults.
Particularly in patients with diabetes or cardiovascular risk factors, myocardial infarction should remain in the differential diagnosis.
Additional warning features may include:
Persistent or sudden upper abdominal discomfort
Nausea and vomiting
Diaphoresis
Dyspnea
Unusual fatigue
Diabetes
Hypertension
Dyslipidemia
Known coronary artery disease
As illustrated by this case, ECG abnormalities and elevated troponin should prompt appropriate cardiac evaluation even when the presenting symptom is not classic chest pain.
Avoiding Unnecessary Imaging
Not every patient suspected of having LVT requires CT, MRI, and multiple echocardiographic examinations.
The key concept is pretest probability.
If there is no myocardial infarction, LV function is preserved, and there is no apical wall-motion abnormality, the probability of LVT is relatively low.
Conversely:
Anterior myocardial infarction + LAD occlusion + apical akinesia + reduced LVEF
creates a much higher pretest probability.
If the initial TTE is negative in such a patient, the first question should be whether the apex was adequately visualized.
When the clinical suspicion remains high, contrast-enhanced TTE or CMR may improve diagnostic confidence.
The goal is therefore not to perform every possible examination, but to select the right examination at the right time.
Expert Insights
Expert Insight 1 — Radiology Perspective
An apical filling defect should be interpreted in conjunction with coronary anatomy and regional wall-motion abnormalities rather than as an isolated finding.
Expert Insight 2 — Emergency Medicine Perspective
Upper abdominal pain and vomiting may represent an atypical presentation of myocardial infarction, particularly in older adults and patients with diabetes.
Expert Insight 3 — Cardiology Perspective
Confirmation of coronary occlusion and assessment of an established LV thrombus represent separate clinical decisions.
Expert Insight 4 — Echocardiography Perspective
LVEF should be interpreted together with apical wall motion, thrombus morphology, protrusion, and mobility.
Expert Insight 5 — CT Perspective
An apical low-attenuation area or filling defect on non-cardiac CT should not automatically be dismissed as contrast-mixing artifact.
Expert Insight 6 — CMR Perspective
When TTE is inconclusive but clinical suspicion remains high, CMR can provide valuable tissue characterization.
Expert Insight 7 — Clinical Workflow Perspective
The most accurate imaging test is not necessarily the most appropriate first-line examination. Accessibility, timing, and patient condition matter.
Expert Insight 8 — Follow-up Perspective
Follow-up should assess not only thrombus resolution but also recovery of LV systolic function.
Expert Insight 9 — Risk Perspective
Embolic risk should be considered using the thrombus location, morphology, protrusion, mobility, and underlying ventricular function rather than size alone.
Expert Insight 10 — Patient Journey Perspective
Recognition of myocardial infarction, detection of LV thrombus, anticoagulation, and follow-up imaging should be viewed as a continuous clinical pathway.
Clinical Pearls
Upper abdominal pain can be an atypical manifestation of myocardial infarction.
Older adults and patients with diabetes may present without classic chest pain.
Extensive LAD territory myocardial infarction is an important risk setting for LVT.
Apical akinesia and dyskinesia are major contributors to thrombus formation.
TTE is an important first-line imaging examination.
A technically limited apical view should not be considered equivalent to a definitive negative examination.
Contrast-enhanced TTE or CMR can be considered when standard TTE is inconclusive.
Thrombus location, morphology, protrusion, and mobility should be documented.
Confirmed LVT generally requires consideration of systemic anticoagulation to prevent embolization.
Anticoagulant selection should balance thromboembolic and bleeding risks.
Follow-up imaging is important to determine whether the thrombus has resolved.
Recovery of LV function should be assessed alongside thrombus resolution.
Persistent apical dyskinesia or LV aneurysm may indicate ongoing thrombotic risk.
Common Diagnostic Pitfalls
Pitfall 1. Assuming Upper Abdominal Pain Is Gastrointestinal
In older or diabetic patients, myocardial infarction should remain in the differential diagnosis.
Pitfall 2. Looking Only at LVEF
A reduced LVEF is important, but regional wall-motion abnormalities—especially apical akinesia or dyskinesia—provide additional information about thrombus risk.
Pitfall 3. Reporting “No Thrombus” When the Apex Is Poorly Visualized
A technically limited study should be distinguished from a truly negative study.
Pitfall 4. Calling Every CT Apical Filling Defect a Thrombus
Contrast-mixing artifacts and pseudo-lesions must be considered, particularly on non-cardiac CT.
Pitfall 5. Reporting Only “LV Thrombus Present”
The report should ideally include location, size, morphology, protrusion, and mobility.
Pitfall 6. Automatically Choosing a Specific Anticoagulant
The choice between DOACs and warfarin should consider bleeding risk, concomitant antiplatelet therapy, renal function, and thromboembolic risk.
Pitfall 7. Ending Follow-up Solely Because the Thrombus Has Resolved
LV function and regional wall motion should also be reassessed.
FAQ
Q1. What is a left ventricular mural thrombus?
A left ventricular mural thrombus is a blood clot that forms along the endocardial surface of the left ventricle, commonly at the apex or an area of myocardial infarction.
Q2. Why does LV thrombus develop after myocardial infarction?
Myocardial infarction can cause severe apical and anterior wall-motion abnormalities, resulting in blood stasis. Myocardial injury and activation of the coagulation system further promote thrombus formation.
Q3. Is a left ventricular thrombus dangerous?
The major concern is systemic embolization. A thrombus can detach and travel to the cerebral or peripheral arterial circulation, potentially causing ischemic stroke or acute organ ischemia.
Q4. Which imaging test is used to detect LVT?
TTE is an important first-line test. Contrast-enhanced TTE or CMR can be considered when visualization is inadequate or clinical suspicion remains high.
Q5. Can CT detect LV thrombus?
Yes. LVT may appear as an apical filling defect on CT, including examinations performed for non-cardiac indications. However, routine CT protocols may have limitations for detecting small thrombi.
Q6. When is cardiac MRI useful?
CMR is particularly useful when echocardiographic findings are equivocal and clinical suspicion remains high. Tissue characterization can help distinguish thrombus from myocardium and other intracardiac masses.
Q7. Does every patient with LV thrombus require anticoagulation?
Confirmed LVT is an important indication to consider systemic anticoagulation, but the specific treatment strategy should be individualized according to thromboembolic and bleeding risks and the overall clinical context.
Q8. How long is anticoagulation continued?
A practical strategy described in the case material is approximately 3 months of anticoagulation followed by repeat imaging. Longer treatment may be considered when thrombus persists or significant risk factors remain.
Q9. Does disappearance of the thrombus mean treatment is finished?
Not necessarily. Recovery of LV systolic function and improvement of regional wall motion should also be considered.
Q10. What is the most important imaging clue?
The combination of:
LAD territory myocardial infarction + apical wall-motion abnormality + apical filling defect or thrombotic structure
should immediately raise concern for left ventricular mural thrombus.
Quiz
Question 1
A woman in her 70s with diabetes presents with upper abdominal pain and vomiting. ECG demonstrates pathological Q waves and precordial T-wave inversions, and troponin is elevated. Coronary angiography demonstrates complete mid-LAD occlusion. Left ventriculography shows an apical filling defect, and echocardiography demonstrates LVEF 37% with an apical thrombus.
What is the most likely diagnosis?
① Rhabdomyoma
② Papillary muscle rupture
③ Sarcoma
④ Left ventricular mural thrombus
⑤ Infective endocarditis vegetation
Correct Answer: ④ Left ventricular mural thrombus
Explanation: The combination of myocardial infarction, LAD occlusion, apical wall-motion abnormality, reduced LV function, and an apical filling defect strongly supports LVT.
Question 2
A patient with myocardial infarction has suspected apical thrombus on echocardiography, but apical visualization is technically inadequate. Clinical suspicion remains high. Which additional imaging modality can provide valuable tissue characterization?
① Chest radiography
② Non-contrast abdominal CT
③ Cardiac MRI
④ Bone scintigraphy
⑤ Brain CT
Correct Answer: ③ Cardiac MRI
Explanation: CMR can provide tissue characterization and may improve diagnostic confidence when echocardiographic findings are inconclusive.
Question 3
Which combination is most important during follow-up of a patient treated for left ventricular thrombus?
① Blood pressure and body temperature only
② LVEF and persistence/resolution of thrombus
③ Serum amylase only
④ Chest radiography only
⑤ ECG only
Correct Answer: ② LVEF and persistence/resolution of thrombus
Explanation: Follow-up should assess both thrombus resolution and recovery of left ventricular function.
Conclusion
Left ventricular mural thrombus is an important complication of myocardial infarction, particularly in patients with anterior or LAD territory myocardial infarction, apical akinesia or dyskinesia, and reduced left ventricular systolic function.
The most important lesson from this case is the need to connect seemingly unrelated clinical findings:
Upper abdominal pain and vomiting → consideration of atypical myocardial infarction → ECG and troponin evaluation → LAD occlusion → apical wall-motion abnormality → evaluation for left ventricular thrombus
Imaging interpretation should never depend on a single finding in isolation.
The coronary anatomy, myocardial territory, regional wall motion, LVEF, thrombus morphology, protrusion, and mobility should be interpreted together within the clinical context.
TTE remains an important initial examination because it is rapid and widely accessible. However, inadequate apical visualization can limit sensitivity. When clinical suspicion remains high despite an equivocal TTE, contrast-enhanced echocardiography or cardiac MRI may improve diagnostic accuracy.
Once LVT is confirmed, anticoagulation becomes an important component of management, with the choice of therapy individualized according to thromboembolic risk, bleeding risk, concomitant antiplatelet therapy, renal function, and other clinical factors.
Follow-up imaging is equally important.
The key questions after treatment are not only:
“Has the thrombus disappeared?”
but also:
“Has left ventricular function recovered?”
Ultimately, the central imaging question is:
“Is this simply an intracardiac mass, or is it a thrombus reflecting the underlying pathophysiology of myocardial infarction and carrying a risk of systemic embolization?”
Recognizing that distinction is at the heart of accurate imaging diagnosis and effective clinical management.
Key Takeaways
Upper abdominal pain may be an atypical presentation of myocardial infarction.
Older adults and patients with diabetes may have myocardial infarction without classic chest pain.
LAD territory myocardial infarction is an important risk setting for LVT.
Apical akinesia and dyskinesia contribute significantly to thrombus formation.
TTE is an important initial imaging modality for LVT.
A technically inadequate apical view should not be considered a definitive negative examination.
Contrast-enhanced TTE or CMR can be considered when diagnostic uncertainty persists.
Thrombus location, size, morphology, protrusion, and mobility should be evaluated.
Confirmed LVT requires consideration of systemic anticoagulation.
Follow-up imaging should assess both thrombus resolution and recovery of LV function.
References
[1] G. N. Levine, J. W. McEvoy, J. C. Fang, et al., “Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association,” Circulation, vol. 146, pp. e205–e223, 2022. DOI: 10.1161/CIR.0000000000001092.
[2] C. P. McCarthy, M. Vaduganathan, K. J. McCarthy, et al., “Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment,” JAMA Cardiology, vol. 3, no. 7, pp. 642–649, 2018. DOI: 10.1001/jamacardio.2018.1086.
[3] M. B. Srichai, C. Junor, L. L. Rodriguez, et al., “Clinical, imaging, and pathological characteristics of left ventricular thrombus,” American Heart Journal, vol. 152, no. 1, pp. 75–84, 2006. DOI: 10.1016/j.ahj.2005.08.021.
[4] J. W. Weinsaft, J. Kim, C. B. Medicherla, et al., “Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR,” JACC: Cardiovascular Imaging, vol. 9, no. 5, pp. 505–515, 2016. DOI: 10.1016/j.jcmg.2015.06.017.
[5] A. Aimo, E. Kollia, G. Ntritsos, et al., “Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: A systematic review and meta-analysis,” Clinical Research in Cardiology, vol. 110, pp. 1697–1703, 2021. DOI: 10.1007/s00392-020-01741-7.
[6] P. M. Haller, N. Kazem, S. Agewall, et al., “Oral anticoagulation in patients with left ventricular thrombus: A systematic review and meta-analysis,” European Heart Journal - Cardiovascular Pharmacotherapy, vol. 10, no. 5, pp. 444–453, 2024. DOI: 10.1093/ehjcvp/pvae042.
[7] T. Hu, C. Chen, K. Maduray, et al., “Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus—A meta-analysis update,” Thrombosis Journal, vol. 22, no. 1, p. 23, 2024. DOI: 10.1186/s12959-024-00585-9.
[8] E. Dan Itaya, U. M. Araujo de Matos, M. D. da Silva Santiago, et al., “Direct oral anticoagulants or warfarin in left ventricular thrombus: An updated systematic review and meta-analysis of randomized trials,” Journal of Thrombosis and Thrombolysis, vol. 59, no. 3, pp. 697–707, 2026. DOI: 10.1007/s11239-025-03214-y.
[9] R. A. Byrne, X. Rossello, J. J. Coughlan, et al., “2023 ESC Guidelines for the management of acute coronary syndromes,” European Heart Journal, 2023.
Medical Disclaimer
This article is intended for medical education and professional discussion. It does not constitute individual medical advice, diagnosis, or treatment. Clinical decisions should be based on the complete clinical history, laboratory findings, imaging studies, current guidelines, and multidisciplinary medical assessment.
Comments
Post a Comment